Monoclonal Antibody Development

High-Specificity mAb Generation for Research, Diagnostics & Therapeutics

​IMD has decades of experiences in generating highly-specific monoclonal antibodies using hybridoma technology, as evidenced by the successful development of a large number of mAbs for research, clinical diagnosis, and therapeutic applications. We know how to generate a mAb that is specific to the immunogens and that works for your intended application. Our state-of-the-art facilities, including GE Biacore 8K and Sartorius Biostat B, ensure superior quality and performance at every step.

​